Invokana tablets contains the medication, Canagliflozin 100mg which helps type-2 diabetics improve control over their blood glucose levels.
Type-2 diabetes is associated with increased risk of cardiovascular disease, blindness, kidney failure and stroke. The addition of Canagliflozin to a diabetes management plan of dietary improvements and regular exercise helps to improve the health outcomes for diabetics who have a shorter life expectancy.
Canagliflozin belongs to the gliflozin group of medications that work by inhibiting the reabsorption of glucose by the kidney. Blood glucose levels are reduced and there is increased glucose excretion in the urine. Often there is a reduction in body weight and reduced blood pressure because of the actions of canagliflozin as a consequence of better blood glucose control.